- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 48
Reglagene shortens cancer cell life
The spinout will develop research on drugs that could one day shorten the lifespan of cancerous cells.
Nov 2, 2017UA targets pain with Regulonix
The Arizona spinout is searching for non-opioid painkillers that target sections of the nerve cell membrane thought responsible for pain disorders.
Nov 2, 2017Columbia welds GreenOre
The university has partnered Baotou Steel to spin out a steel waste recycling and carbon capturing system due to launch in China by mid-2018.
Oct 30, 2017ABLS IV targets autoimmune diseases
The Cornell University spinout will look at inhibitor drugs that could better fight autoimmune and inflammatory diseases.
Oct 30, 2017PCI unveils better deal for inventors
University of Pennsylvania inventors will now be paid their cut of licensing fees faster while also benefiting from a reduced initial deduction.
Oct 18, 2017Fortress builds on Columbia licence
Biopharmaceutical developer Fortress Biotech has set up a new subsidiary to develop a treatment for amyloidosis licensed from Columbia University.
Oct 17, 2017Lunewave targets radar system
Lunewave has been spun out of UA to develop 3D printable radar technology that could one day be integrated into the advanced driver assistance systems on automobiles.
Oct 16, 2017Trio triangulates $6.6m for collaboration
The universities of Manchester, Leeds and Sheffield have received government funding to improve the commercialisation ecosystem in northern England.
Oct 16, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


